The biopharma industry has long recognized the important role of clinical specialists in guiding drug development and informing medical strategies to ensure ‘safe and appropriate’ use. These key opinion leaders (aka thought leaders) are predominantly drawn from academic centers of excellence and are respected figures in a field of medicine relevant to the disease or treatment being developed.
Swiss drugmaker Roche will team up with privately held biotech Ascidian Therapeutics to develop gene therapies targeting difficult to treat neurological diseases, the Boston-based startup said on Tuesday.
The world’s largest independent health agency kicks off creativity festival with a Gold Pharma Lion, Bronze Health & Wellness Lion, plus #2 Health Agency and #2 Health Network of the Year titles for the second year running.
AstraZeneca on Tuesday announced that its AKT inhibitor Truqap, when used in combination with paclitaxel, failed to meet its primary efficacy endpoint in the Phase III CAPItello-290 study in patients with metastatic triple-negative breast cancer.
Amazon.com’s pharmacy unit said on Tuesday it is expanding eligibility for its monthly subscription service, which covers a range of generic drugs, to those enrolled in government-backed Medicare insurance plans.
The FDA on Monday greenlit Merck’s 21-valent pneumococcal conjugate vaccine to prevent invasive pneumococcal disease and pneumococcal pneumonia in adults.